AI eye in the scope: new tool aims to catch stomach cancer earlier
NCT ID NCT07395570
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an artificial intelligence system (called CADe) can help doctors spot early stomach cancers during endoscopy. About 260 people at high risk for stomach cancer will have two endoscopies: one without the AI and one with it. The goal is to see if the AI reduces the number of cancers that are missed. If it works, this could lead to earlier treatment and better survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CADe System (artificial intelligence software for endoscopy)
What this could lead to
If successful, this AI tool could help doctors find early stomach cancers more reliably, potentially improving survival rates by catching the disease sooner.
What could go wrong
This is a small, early-stage study (260 participants) testing a prototype system. The AI may not work as well in real-world settings or for all types of gastric lesions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC NEOPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong
Hong Kong, Hong Kong